Antibody to Oligodendrocyte Marker O1

<strong>Antibody to Oligodendrocyte Marker O1</strong>_x000D_ <strong>Catalog number:</strong> B2015518_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> Purified anti-Oligodendrocyte Marker O1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Tracy ET, Zhang CY, Gentry T, Shoulars KW, Kurtzberg J. Isolation and expansion of oligodendrocyte progenitor cells from cryopreserved human umbilical cord blood Cytotherapy. 2011 Jul;13(6):722-9._x000D_ 2: Ahmad I, Wergeland S, Oveland E, B√∏ L. A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination PLoS One. 2021 Aug 26;16(8):e0256155._x000D_ 3: Abbaszadeh HA, Tiraihi T, Delshad AR, Saghedi Zadeh M, Taheri T. Bone marrow stromal cell transdifferentiation into oligodendrocyte-like cells using triiodothyronine as a inducer with expression of platelet-derived growth factor Œ± as a maturity marker Iran Biomed J. 2013 Apr;17(2):62-70._x000D_ 4: Pinezich MR, Russell LN, Murphy NP, Lampe KJ. Encapsulated oligodendrocyte precursor cell fate is dependent on PDGF-AA release kinetics in a 3D microparticle-hydrogel drug delivery system J Biomed Mater Res A. 2018 Sep;106(9):2402-2411._x000D_ 5: Bansal R, Pfeiffer SE. FGF-2 converts mature oligodendrocytes to a novel phenotype J Neurosci Res. 1997 Oct 15;50(2):215-28._x000D_ 6: Tracy ET, Zhang CY, Gentry T, Shoulars KW, Kurtzberg J. Isolation and expansion of oligodendrocyte progenitor cells from cryopreserved human umbilical cord blood Cytotherapy. 2011 Jul;13(6):722-9._x000D_ 7: Chadar√©vian JP, Legido A, Halligan GE, Faerber EN, Piatt JH, Morrissette JD, Ara J, Grant ML, Katsetos CD. Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature J Child Neurol. 2012 Apr;27(4):511-20._x000D_ 8: Hirahara Y, Bansal R, Honke K, Ikenaka K, Wada Y. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice Glia. 2004 Feb;45(3):269-77._x000D_ 9: Rivkin MJ, Flax J, Mozell R, Osathanondh R, Volpe JJ, Villa-Komaroff L. Oligodendroglial development in human fetal cerebrum Ann Neurol. 1995 Jul;38(1):92-101._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/29546710">10: Monje PV. Scalable Differentiation and Dedifferentiation Assays Using Neuron-Free Schwann Cell Cultures Methods Mol Biol. 2018;1739:213-232. </a>_x000D_ _x000D_ <strong>Products Related to Antibody to Oligodendrocyte Marker O1 can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>